Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;28(5):679-87.
doi: 10.1007/s00467-012-2222-9. Epub 2012 Aug 17.

Renal complications of Fabry disease in children

Affiliations
Review

Renal complications of Fabry disease in children

Behzad Najafian et al. Pediatr Nephrol. 2013 May.

Abstract

Fabry disease is an X-linked α-galactosidase A deficiency, resulting in accumulation of glycosphingolipids, especially globotriaosylceramide, in cells in different organs in the body. Renal failure is a serious complication of this disease. Fabry nephropathy lesions are present and progress in childhood while the disease commonly remains silent by routine clinical measures. Early and timely diagnosis of Fabry nephropathy is crucial since late initiation of enzyme replacement therapy may not halt progressive renal dysfunction. This may be challenging due to difficulties in diagnosis of Fabry disease in children and absence of a sensitive non-invasive biomarker of early Fabry nephropathy. Accurate measurement of glomerular filtration rate and regular assessment for proteinuria and microalbuminuria are useful, though not sensitive enough to detect early lesions in the kidney. Recent studies support the value of renal biopsy in providing histological information relevant to kidney function and prognosis, and renal biopsy could potentially be used to guide treatment decisions in young Fabry patients. This review aims to provide an update of the current understanding, challenges, and needs to better approach renal complications of Fabry disease in children.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electron Micrograph of a glomerulus from an 11-years-old boy with Fabry disease. The patient had normal GFR and a urine protein/creatinine ratio of about 40 mg/g at biopsy. There are abundant GL-3 inclusions (long black arrows) in podocytes (PC). Similar inclusions are found in endothelial cells (white arrow) and mesangial cells (spiral arrow). Short black arrows show widened foot processes over a capillary (Cap) loop. Arrowheads show loss of fenestration in an endothelial cell. Magnification: 35,000 x.
Figure 2
Figure 2
A. Mild Fabry arteriopathy characterized by focal replacement of smooth muscle cells in the vascular wall by hyaline-like material (arrow) in a kidney biopsy from a 12-years-old girl with Fabry disease, PAS stain, 40x. The patient had normal GFR and a urine protein/creatinine ratio of 90 mg/g at biopsy. B. More severe Fabry arteriopathy from an autopsy case. Arrows show that a substantial portion of the muscular wall is replaced y the hyaline-like material, H&E, 20x.
Figure 3
Figure 3
Relationships between urine protein creatinine ratio (UPCR) and age with foot process width (FPW) and podocyte GL-3 inclusion density [Vv(Inc/PC)] in young Fabry patients. Both Vv(Inc/PC) and FPW increased with age and correlated with UPCR, although these relationships were more prominent in male patients (black circles) compared to females (white circles). (adapted and modified from Najafian et al., Ref. 18).

Similar articles

Cited by

References

    1. Tsutsumi O, Sato M, Sato K, Mizuno M, Sakamoto S. Early prenatal diagnosis of inborn error of metabolism: a case report of a fetus affected with Fabry’s disease. Asia Oceania J Obstet Gynaecol. 1985;11:39–45. - PubMed
    1. Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, Lemay R, Tylki-Szymanska A, Wilcox WR. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res. 2008;64:550–555. - PubMed
    1. Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79:31–40. - PMC - PubMed
    1. Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, Sorensen SA, Wilcox WR, Desnick RJ. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant. 2009;24:2102–2111. - PMC - PubMed
    1. Meroni M, Spisni C, Tazzari S, Di Vito R, Stingone A, Bovan I, Torri Tarelli L, Sessa A. Isolated glomerular proteinuria as the only clinical manifestation of Fabry’s disease in an adult male. Nephrol Dial Transplant. 1997;12:221–223. - PubMed

Publication types

MeSH terms

Substances